Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF

על הניסוי

This study evaluates the ability of the drug sildenafil to improved exercise capacity, cardiac performance during exercise, and quality of life in patients with moderate to severe CF lung disease. 3/4 of the subjects will receive sildenafil and 1/4 will receive placebo.

צפו ב-NCT02626182 ב-ClinicalTrials.gov ←

קישורים קשורים

ניסויים קשורים